G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
Neuromolecular Med
; 24(4): 392-398, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-35113321
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cerebellar Neoplasms
/
Medulloblastoma
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Neuromolecular Med
Journal subject:
BIOLOGIA MOLECULAR
/
NEUROLOGIA
Year:
2022
Type:
Article
Affiliation country:
Brazil